Caregiver Burden and Neuropsychiatric Symptoms in Older Adults With Cognitive Impairment The Aging, Demographics, and Memory Study (ADAMS)

Section of Geriatric Medicine, Bajikoen Clinic, Tokyo, Japan.
Alzheimer disease and associated disorders (Impact Factor: 2.44). 12/2010; 25(2):116-21. DOI: 10.1097/WAD.0b013e318203f208
Source: PubMed


To estimate the quantity of informal care associated with neuropsychiatric symptoms in older adults with cognitive impairment.
Cross-sectional analysis.
The Aging, Demographics, and Memory Study.
A sample (n=450) of adults aged 71 years and older with cognitive impairment drawn form the Health and Retirement Study.
The presence of neuropsychiatric symptoms (delusions, hallucinations, agitation, depression, apathy, elation, anxiety, disinhibition, irritation, and aberrant motor behaviors) was identified using the neuropsychiatric inventory. Cognitive category [normal, cognitive impairment without dementia (CIND), or dementia] was assigned by a consensus panel. The hours per week of active help and supervision were ascertained by informant questionnaire.
Among older adults with CIND or dementia, those with no neuropsychiatric symptoms received an average of 10.2 hours of active help and 10.9 hours of supervision per week from informal caregivers. Those with 1 or 2 neuropsychiatric symptoms received an additional 10.0 hours of active help and 12.4 hours of supervision per week, while those with 3 or more symptoms received an additional 18.2 hours of active help and 28.7 hours of supervision per week (P<0.001). The presence of irritation (14.7 additional hours) was associated with the greatest number of additional hours of active help. The presence of aberrant motor behaviors (17.7 additional hours) and disinhibition (17.5 additional hours) were associated with the greatest number of additional hours of supervision.
Neuropsychiatric symptoms among those with CIND or dementia are associated with a significant increase in the provision of informal care. This care represents a significant time commitment for families and a significant economic cost to society.

Download full-text


Available from: Kenneth Langa,
  • Source
    • "In addition to the cognitive impairments of Alzheimer's disease (AD), the neuropsychiatric symptoms (NPS) that frequently accompany dementia [1] [2] [3] [4] have a significant impact on patients and caregivers alike and are a major factor in caregiver stress [5] [6] [7], decline in cognition, quality of life [8] [9], and nursing home placement [10]. Although apathy and depression are the most frequently occurring NPS [11], psychosis [12], agitation [2], and disturbances of sleep [13] are prevalent. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous serum and plasma based biomarkers of systemic inflammation have been linked to both neuropsychiatric disorders and Alzheimer's disease (AD). The present study investigated the relationship of clinical biomarkers of cardiovascular risk (cholesterol, triglycerides, and homocysteine) and a panel of markers of systemic inflammation (CRP, TNF-α, IL1-ra, IL-7, IL-10, IL-15, IL-18) and microvascular pathology (ICAM-1, VCAM-1) to neuropsychiatric symptoms in a sample with mild AD. Biomarker data was analyzed on a sample of 194 diagnosed with mild to moderate probable AD. The sample was composed of 127 females and 67 males. The presence of neuropsychiatric symptoms was gathered from interview with caretakers/family members using the Neuropsychiatric Inventory. For the total sample, IL-15, VCAM (vascular adhesion molecule), and triglycerides were significantly and negatively related to number of neuropsychiatric symptoms, and total cholesterol and homocysteine were positively related and as a group accounted for 16.1% of the variance. When stratified by gender, different patterns of significant biomarkers were found with relationships more robust for males for both total symptoms and symptom clusters. A combination of biomarkers of systemic inflammation, microvascular pathology, and clinical biomarkers of cardiovascular risk can account for a significant portion of the variance in the occurrence of neuropsychiatric symptoms in AD supporting a vascular and inflammatory component of psychiatric disorders found in AD. Gender differences suggest distinct impact of specific risks with total cholesterol, a measure of cardiovascular risk, being the strongest marker for males and IL-15, a marker of inflammation, being the strongest for females.
    Journal of Alzheimer's disease: JAD 02/2013; 35(2). DOI:10.3233/JAD-122359 · 4.15 Impact Factor

  • Alzheimer's and Dementia 07/2011; 7(4). DOI:10.1016/j.jalz.2011.05.456 · 12.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The research was performed to determine the problems that caregivers experience with patients with Alzheimer disease. The research was carried out qualitatively with those who were responsible for the care of eight Alzheimer patients who were being treated at the Neurology Polyclinics of Gevher Nesibe Hospital at Erciyes University in Kayseri, Turkey. Research data were collected through questionnaires designed to understand the characteristics of the individuals who provided care and focus group interviews. A written consent from the institution and an oral as well as written consent of the individuals were obtained. Focus groups were interviewed in the same setting at different times with two different groups, including four people who agreed to participate in the research. Each interview was conducted by three personnel: a moderator, a reporter, and an observer. Interviews were structured under four main titles: "The changes seen in the individual with Alzheimer disease"; "Physical, social, psychological, and socioeconomical problems that caregivers experienced"; "Precautions taken against the problems"; and "Patients' expectations of the care". The interviews lasted for approximately 2 hours. A voice recorder and a written registration form were also used to collect information. Six women and two men constituted the research group. The caregivers stated that the patients had such difficulties as forgetfulness, nervousness, jealousy, childish behavior, deterioration in speech, fear of water, hallucinations, and difficulty in carrying out daily life activities. Caregivers emphasized the fact that they perceived the changes in the patients as deliberate behaviors and thus became annoyed and quarreled with them before diagnosis; however, after diagnosis, they felt remorse and experienced guilt because of their ill-treatment of them. In addition, the caregivers hid the patients and their disease from social surroundings. Caregivers mentioned that they had felt as someone who was helpless, exhausted, and abandoned; they lost their freedom and lacked their taste for life. They felt no confidence in someone else caring for the patient; thus, they neglected their own personal needs. Caregivers reported that they often cried and started to smoke because of these problems. They took precautions, such as making identity cards, helping the patients with their daily life activities, not changing the current order at home, and not leaving the patients alone. Caregivers expressed a desire for assistance from home healthcare personnel, a reliable nursing home where they could leave the patient, and a support group to whom they could share their problems. It was found that the caregivers who provided care to patients with Alzheimer disease experienced multidimensional problems, could not find any professional support, and needed institutional assistance.
    08/2012; 44(4):228-34. DOI:10.1097/JNN.0b013e3182527627
Show more